The neurofibromatosis type 1 market remains niche, but awareness campaigns, increased diagnoses, and treatment adoption, along with ongoing clinical trials, will expand the NF1 therapeutics market ...
Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Neurofibromatosis Type 1 - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report delivers in-depth insights into the ...
Neurofibromatosis type 1 is an autosomal dominant disorder that affects multiple organ systems and has a wide range of variable clinical manifestations. It is one of three conditions described under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results